# GW786034 in Treating Patients With Advanced Solid Tumors

> **NCT00060151** · PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** pazopanib hydrochloride

## Key facts

- **NCT ID:** NCT00060151
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060151, "GW786034 in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00060151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*